New Combination Treatment for Advanced Bladder Cancer Approved by NHS London, United Kingdom – A new combination treatment has been approved for use on the NHS for patients with advanced bladder cancer. The treatment, a combination of enfortumab vedotin (Padcev) and pembrolizumab (Keytruda), has been found to significantly improve survival rates and shrink tumors in patients compared to…
No responses yet